Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer

被引:14
作者
Bjornland, K [1 ]
Flatmark, K
Mala, T
Mathisen, O
Bakka, A
Aasen, AO
Bergan, A
Soreide, O
Fodstad, O
机构
[1] Univ Oslo, Rikshosp, Dept Surg, N-0027 Oslo, Norway
[2] Univ Hosp, Rikshosp, Inst Surg Res, Oslo, Norway
[3] Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway
[4] Inst Canc Res, Oslo, Norway
关键词
liver metastases; liver resection; micrometastasis; bone marrow micrometastases; MOC; 31;
D O I
10.1002/jso.10223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: In colorectal cancer (CRC) patients, tumour recurrence is common following potentially curative surgery for liver metastases. This may be caused by occult tumour cells present at the time of surgery. Dissemination of micrometastatic cells may occur early in patients with solid cancer, and micrometastases may signify a poor prognosis. The aim of the present study was to evaluate the frequency of micrometastatic cells in the bone marrow of patients with potentially resectable liver metastases. Methods: Twenty millilitres of bone marrow was aspirated from both anterior iliac crests from 48 patients. Mononuclear cells were isolated and incubated with superparamagnetic Dynabeads((R)) coated with an anti-epithelial monoclonal antibody (MOC3 1). Magnetically selected cells were identified by light microscopy as cells with bead rosettes (>5 beads/cell). Results: Micrometastatic tumour cells were identified in four of 48 (8%) patients who all had their liver rnetastases surgically removed. Two of the four died after 17 and 18 months, respectively, whereas two are alive after 10 and 12 months. None of the 19 inoperable patients had micrometastases. Conclusions: The frequency of bone marrow micrometastases in patients with clinically isolated liver metastases from CRC was low. This is biologically interesting, but bone marrow status should not affect current treatment protocols.
引用
收藏
页码:224 / 227
页数:4
相关论文
共 25 条
[1]  
Borgen E, 1998, J PATHOL, V185, P427, DOI 10.1002/(SICI)1096-9896(199808)185:4<427::AID-PATH127>3.0.CO
[2]  
2-7
[3]   Micrometastatic bone marrow involvement: detection and prognostic significance [J].
Braun, S ;
Pantel, K .
MEDICAL ONCOLOGY, 1999, 16 (03) :154-165
[4]   In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases [J].
Cohen, AM ;
Garin-Chesa, P ;
Hanson, M ;
Weyhrauch, K ;
Kemeny, N ;
Fong, YM ;
Paty, P ;
Welt, S ;
Old, L .
DISEASES OF THE COLON & RECTUM, 1998, 41 (09) :1112-1115
[5]   Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases [J].
Figueras, J ;
Valls, C ;
Rafecas, A ;
Fabregat, J ;
Ramos, E ;
Jaurrieta, E .
BRITISH JOURNAL OF SURGERY, 2001, 88 (07) :980-985
[6]  
Flatmark K, 2002, CLIN CANCER RES, V8, P444
[7]  
Fodstad O, 2001, RECENT RES CANCER, V158, P40
[8]   Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases [J].
Fong, Y ;
Fortner, J ;
Sun, RL ;
Brennan, MF ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 230 (03) :309-318
[9]   Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated [J].
Funke, I ;
Schraut, W .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :557-566
[10]  
Hardingham JE, 2000, INT J CANCER, V89, P8, DOI 10.1002/(SICI)1097-0215(20000120)89:1<8::AID-IJC2>3.0.CO